New heart valve study tracks safety in chinese patients over time

NCT ID NCT05404880

Ongoing Disease control Sponsor: Edwards Lifesciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 255 Chinese patients who received the INSPIRIS RESILIA aortic valve to see how safe and well it works over several years. Researchers track problems like valve failure, blood clots, bleeding, and the need for another surgery. The goal is to confirm the valve's long-term performance in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE REPLACEMENT

Contacts and locations

Locations

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, 100029, China
Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, 451460, China
Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen

Shenzhen, Guangdong, 518038, China
Fuwai Hospital, CAMS & PUMC

Beijing, Beijing Municipality, 100037, China
Fuwai Yunnan Cardiovascular Hospital

Kunming, Yunnan, 650102, China
Henan Provincial Chest Hospital

Zhengzhou, Henan, 450008, China
Nanjing First Hospital

Nanjing, Jiangsu, 210012, China
Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital

Chengdu, Sichuan, 610072, China
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Hefei, Anhui, 230002, China
The First Affiliated Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, 710065, China
The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450052, China
The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China
Xiamen Cardiovascular Hospital Xiamen University

Xiamen, Fujian, 361008, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.